New research shows Australians aren’t taking ageing lying down
Read more - New research shows Australians aren’t taking ageing lying down Read more
Press releases
These press releases are intended for business journalists and analysts/investors
Luke Miels appointed President, Global Pharmaceuticals, GSK
Read more - Luke Miels appointed President, Global Pharmaceuticals, GSK Read more
New treatment option available January 1 2017 for patients with a form of severe asthma
First therapy approved for severe refractory eosinophilic asthma to be listed on the PBS
Santa’s prostate nightmare urges Australian men to act
What would happen to Christmas if Santa suffered prostate issues?
#SeatsUpForSanta social initiative puts spotlight on enlarged prostate symptoms
Read more - Santa’s prostate nightmare urges Australian men to act Read more
GSK invests to support female technology entrepreneurs
Read more - GSK invests to support female technology entrepreneurs Read more
GSK leads Access to Medicine Index 2016
GSK tops the Access to Medicines Index for the fifth consecutive time.
Read more - GSK leads Access to Medicine Index 2016 Read more
GSK Consumer Healthcare to close Ermington manufacturing site in 2020
GSK Consumer Healthcare announced that it will close its manufacturing facility at Ermington, in Sydney’s north-west, in 2020. The decision was made after a thorough evaluation of the site, which revealed the manufacturing site would not be able to remain competitive in the long-term.
All entitlements are protected for the 223 employees whose jobs are affected, and the company will work through the next four years to provide support.
Read more - GSK Consumer Healthcare to close Ermington manufacturing site in 2020 Read more
Bexsero® (Meningococcal B) vaccine availability
Read more - Bexsero® (Meningococcal B) vaccine availability Read more
GSK founding partner for Victorian Medicines Manufacturing Innovation Centre
GSK invests in Victorian manufacturing with Monash and the Victorian Government as founding partner of the Medicines Manufacturing Innovation Centre.
Read more - GSK founding partner for Victorian Medicines Manufacturing Innovation Centre Read more
Whooping cough vaccines availability update
GSK prioritises whooping cough vaccine availability for those most at risk of the disease and confirms uninterrupted supply of Boostrix® and Boostrix® IPV to all Australian State, Territory and Federal Government vaccination programs where Boostrix/Boostrix-IPV is the vaccine of choice.
Read more - Whooping cough vaccines availability update Read more
